PIN18 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in New Zealand

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.265 ◽

2020 ◽

Vol 22 ◽

pp. S51

Author(s):

S. Mohanty ◽

I. Sukarom ◽

K. Owusu-Edusei ◽

T. Hu

Keyword(s):

New Zealand ◽

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine

Download Full-text

CLARIFICATION OF IMMUNISATION STATUS DURING PNEUMOCOCCAL CONJUGATE VACCINE SWITCHES IN NEW ZEALAND

10.26226/morressier.5ad774ded462b80296ca6a4f ◽

2018 ◽

Author(s):

Bruce Mungall

Keyword(s):

New Zealand ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Immunisation Status

Download Full-text

PIN41 HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV15) SEROTYPES IN CHILDREN IN THE UNITED STATES

Value in Health ◽

10.1016/j.jval.2019.04.911 ◽

2019 ◽

Vol 22 ◽

pp. S201

Author(s):

T. Hu ◽

T. Petigara ◽

E. Elbasha

Keyword(s):

United States ◽

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine ◽

The United States

Download Full-text

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand

Applied Health Economics and Health Policy ◽

10.1007/s40258-018-0387-5 ◽

2018 ◽

Vol 16 (3) ◽

pp. 331-345 ◽

Author(s):

Lijoy Varghese ◽

Louise Talbot ◽

Andrea Govender ◽

Xu-Hao Zhang ◽

Bruce A. Mungall

Keyword(s):

New Zealand ◽

Cost Effectiveness ◽

Haemophilus Influenzae ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Mass Vaccination ◽

Effectiveness Analysis ◽

Universal Mass Vaccination

Download Full-text

ECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR NEW ZEALAND ADULTS AGED ≥65 YEARS

10.26226/morressier.5731f0d6d462b8029237fc22 ◽

2016 ◽

Author(s):

Kylie Earle

Keyword(s):

Economic Evaluation ◽

New Zealand ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine

Download Full-text

AVERTED COSTS OF PNEUMONIA HOSPITALIZATIONS AFTER PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) INTRODUCTION IN BRAZIL: USE OF NATIONWIDE SECONDARY DATA TO ASSESS IMPACT ON ECONOMIC BURDEN

10.26226/morressier.5731f0d2d462b802923803fa ◽

2016 ◽

Author(s):

Cristiana Toscano

Keyword(s):

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine ◽

Download Full-text

Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis

PLoS ONE ◽

10.1371/journal.pone.0184204 ◽

2017 ◽

Vol 12 (9) ◽

pp. e0184204 ◽

Author(s):

Ana Lucia Andrade ◽

Eliane T. Afonso ◽

Ruth Minamisava ◽

Ana Luiza Bierrenbach ◽

Elier B. Cristo ◽

...

Keyword(s):

Time Series ◽

Time Series Analysis ◽

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine ◽

Vaccine Introduction ◽

Series Analysis ◽

Indirect Impact

Download Full-text

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States

Journal of Medical Economics ◽

10.1080/13696998.2020.1840216 ◽

2020 ◽

pp. 1-8

Author(s):

Tianyan Hu ◽

Thomas Weiss ◽

Kwame Owusu-Edusei ◽

Tanaz Petigara

Keyword(s):

United States ◽

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine ◽

The United States ◽

Vaccine Serotypes

Download Full-text

PIN43 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in South Korea

Value in Health ◽

10.1016/j.jval.2020.08.884 ◽

2020 ◽

Vol 23 ◽

pp. S551

Author(s):

S. Mohanty ◽

I. Sukarom ◽

G. Yang ◽

J. Park ◽

K. Owusu-Edusei ◽

...

Keyword(s):

South Korea ◽

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine

Download Full-text

Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries

Journal of Medical Economics ◽

10.1080/13696998.2021.1970975 ◽

2021 ◽

pp. 1-1

Author(s):

Tianyan Hu ◽

Thomas Weiss ◽

Goran Bencina ◽

Kwame Owusu-Edusei ◽

Tanaz Petigara

Keyword(s):

Conjugate Vaccine ◽

Invasive Pneumococcal Disease ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine ◽

Pneumococcal Disease ◽

European Countries ◽

Vaccine Serotypes

Download Full-text

PIN37 HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE SEROTYPES IN CHILDREN IN THREE EUROPEAN COUNTRIES

Value in Health ◽

10.1016/j.jval.2019.09.1281 ◽

2019 ◽

Vol 22 ◽

pp. S646

Author(s):

T. Hu ◽

G. Bencina ◽

T. Petigara ◽

E. Elbasha

Keyword(s):

Conjugate Vaccine ◽

Economic Burden ◽

Pneumococcal Conjugate Vaccine ◽

European Countries ◽

Vaccine Serotypes

Download Full-text